"SP to be much better in 6 months simply because Adapt sales should be double where they are now."
Thats my reason for investing and helping with the CR also.
But there's a real risk, which is that they run into a problem with the animal testing of the TAVR. If that should happen then the SP will stumble. On the other hand succesful trials should be a help.
"SP to be much better in 6 months simply because Adapt sales...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.33 |
Change
-0.100(0.87%) |
Mkt cap ! $239.5M | |||
| Open | High | Low | Value | Volume |
| $11.45 | $11.50 | $11.33 | $11.79K | 1.031K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 154 | $11.33 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.49 | 639 | 1 |
View Market Depth
| Last trade - 10.18am 15/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |